Does free or lower cost smoking cessation medication stimulate quitting? Findings from the International Tobacco Control (ITC) Netherlands and UK surveys

Objective: To investigate whether mentioning free or lower cost smoking cessation medication as a trigger for thinking about quitting is related to higher medication use, more quit attempts and quit success, and whether these associations are modified by education and income. Methods: Data were derived from the 2013 and 2014 surveys of the International Tobacco Control Netherlands (n=1164) and UK (n=768) cohort. Logistic regression analyses were used to assess associations between mentioning in 2013 that free/lower cost smoking cessation medication was a trigger for thinking about quitting smo... Mehr ...

Verfasser: Van Den Brand, Floor A.
Nagelhout, Gera E.
Hummel, Karin
Willemsen, Marc C.
McNeill, Ann
Van Schayck, Onno C.P.
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: Van Den Brand , F A , Nagelhout , G E , Hummel , K , Willemsen , M C , McNeill , A & Van Schayck , O C P 2018 , ' Does free or lower cost smoking cessation medication stimulate quitting? Findings from the International Tobacco Control (ITC) Netherlands and UK surveys ' , Tobacco Control . https://doi.org/10.1136/tobaccocontrol-2017-054023
Schlagwörter: cessation / price / socioeconomic status
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27588563
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://kclpure.kcl.ac.uk/portal/en/publications/6b3199a3-0dfc-486e-a9d3-a95113ff5ff1

Objective: To investigate whether mentioning free or lower cost smoking cessation medication as a trigger for thinking about quitting is related to higher medication use, more quit attempts and quit success, and whether these associations are modified by education and income. Methods: Data were derived from the 2013 and 2014 surveys of the International Tobacco Control Netherlands (n=1164) and UK (n=768) cohort. Logistic regression analyses were used to assess associations between mentioning in 2013 that free/lower cost smoking cessation medication was a trigger for thinking about quitting smoking and the use of medication, quit attempts and smoking cessation in 2014. Results: 37.0% of smokers in the UK and 24.9% of smokers in the Netherlands mentioned free/lower cost medication as a trigger for thinking about quitting. Smokers who mentioned this trigger were more likely to have used cessation medication during a quit attempt both in the UK (OR=4.19, p<0.001) and in the Netherlands (OR=2.14, p=0.033). The association between mentioning free/lower cost medication as a trigger for thinking about quitting and actual quit attempts was significant in the UK (OR=1.45, p=0.030), but not in the Netherlands (OR=1.10, p=0.587). There was no significant association with quit success. Associations did not differ across income and education groups. Conclusion: Free/lower cost smoking cessation medication may increase the use of cessation medication and stimulate quit attempts among smokers with low, moderate and high education and income.